Contract 36E79724A0031
Horizon Therapeutics USA, Inc. · Department Of Veterans Affairs · September 4, 2024
Horizon Therapeutics USA, Inc. was awarded a federal contract by Department Of Veterans Affairs on September 4, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ 36F79719D0224. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 29, 2025. If all options are exercised, the contract could reach $31.38 million.
Contract details
- PIID
- 36E79724A0031
- Parent IDIQ
- 36F79719D0224
- Award type
- Bpa
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 4, 2024
- Latest action
- October 29, 2025
Description
BPA CANCELLATION
Modification timeline
-
October 29, 2025Mod P00004 · Legal Contract Cancellation$0
-
August 26, 2025Mod P00003 · Exercise An OptionEXERCISE OPTION YEAR 1$0
-
December 22, 2024Mod P00001$0
-
September 4, 2024Base awardBPA FOR RAVICTI, BUPHENYL, KRYSTEXXA, PROCYSBI, UPLIZNA$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79724A0031?
Contract 36E79724A0031 is a federal contract awarded to Horizon Therapeutics USA, Inc. by Department Of Veterans Affairs on September 4, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 36E79724A0031?
Horizon Therapeutics USA, Inc. won contract 36E79724A0031 from Department Of Veterans Affairs.
How much is contract 36E79724A0031 worth?
Contract 36E79724A0031 has obligated $0 to date but carries a potential ceiling of $31.38 million if fully funded and all options are exercised.